| Primary |
| Product Used For Unknown Indication |
18.0% |
| Acquired Haemophilia |
13.4% |
| Factor Viii Inhibition |
13.2% |
| Haemophilia |
8.8% |
| Haemostasis |
8.6% |
| Factor Viii Deficiency |
6.6% |
| Prophylaxis |
4.6% |
| Haemorrhage |
3.4% |
| Pain |
3.2% |
| Off Label Use |
2.8% |
| Post Procedural Haemorrhage |
2.6% |
| Tooth Abscess |
2.0% |
| Drug Use For Unknown Indication |
1.8% |
| Haemorrhage Prophylaxis |
1.8% |
| Premedication |
1.8% |
| Diabetes Mellitus |
1.6% |
| Hypertension |
1.6% |
| Insomnia |
1.6% |
| Anaemia |
1.4% |
| Haemarthrosis |
1.4% |
|
| Hepatitis B Surface Antibody Positive |
12.8% |
| Drug Ineffective |
10.4% |
| Renal Failure |
9.6% |
| Factor Viii Inhibition |
7.2% |
| Blood Fibrinogen Decreased |
5.6% |
| Haemorrhage |
5.6% |
| Haemorrhagic Stroke |
5.6% |
| Disseminated Intravascular Coagulation |
4.8% |
| Hepatitis B Antibody Positive |
4.8% |
| Haemarthrosis |
4.0% |
| Pneumonia |
4.0% |
| Anaphylactic Shock |
3.2% |
| Death |
3.2% |
| Fibrin D Dimer Increased |
3.2% |
| Ischaemic Stroke |
3.2% |
| Vomiting |
3.2% |
| Cerebrovascular Accident |
2.4% |
| Deep Vein Thrombosis |
2.4% |
| Drug Effect Decreased |
2.4% |
| Post Procedural Haemorrhage |
2.4% |
|
| Secondary |
| Factor Viii Inhibition |
46.4% |
| Prophylaxis |
19.3% |
| Product Used For Unknown Indication |
5.9% |
| Acquired Haemophilia |
5.8% |
| Factor Viii Deficiency |
4.5% |
| Pain |
2.2% |
| Haemophilia |
1.8% |
| Haemostasis |
1.8% |
| Premedication |
1.7% |
| Haemorrhage |
1.3% |
| Haematoma |
1.3% |
| Tooth Abscess |
1.3% |
| Depression |
1.1% |
| Haemarthrosis |
1.1% |
| Hypertension |
0.9% |
| Anaemia |
0.9% |
| Infection Prophylaxis |
0.7% |
| Muscle Haemorrhage |
0.7% |
| Agitation |
0.6% |
| Constipation |
0.6% |
|
| Hepatitis B Surface Antibody Positive |
76.5% |
| Hepatitis B Surface Antigen Positive |
7.0% |
| Haemarthrosis |
4.2% |
| Blood Fibrinogen Decreased |
2.5% |
| Hepatitis B Antibody Positive |
1.7% |
| Oedema Peripheral |
1.3% |
| Pneumonia |
1.0% |
| Drug Effect Decreased |
0.8% |
| Enterobacter Infection |
0.8% |
| Drug Ineffective |
0.7% |
| Thrombophlebitis Superficial |
0.7% |
| Renal Failure |
0.4% |
| Leukocytosis |
0.4% |
| Factor Viii Inhibition |
0.4% |
| Ileus Paralytic |
0.4% |
| Haemorrhage |
0.3% |
| Thrombosis |
0.3% |
| Disseminated Intravascular Coagulation |
0.2% |
| Vomiting |
0.2% |
| Arthralgia |
0.2% |
|
| Concomitant |
| Hiv Infection |
22.9% |
| Acquired Haemophilia |
10.2% |
| Drug Use For Unknown Indication |
9.3% |
| Haemophilia A With Anti Factor Viii |
8.5% |
| Immunosuppressant Drug Therapy |
7.6% |
| Haemostasis |
5.9% |
| Factor Viii Deficiency |
4.2% |
| Haemorrhage |
4.2% |
| Retroperitoneal Haematoma |
3.4% |
| Diarrhoea |
2.5% |
| Haemarthrosis |
2.5% |
| Haemophilia |
2.5% |
| Hepatitis C |
2.5% |
| Insomnia |
2.5% |
| Muscle Haemorrhage |
2.5% |
| Adverse Event |
1.7% |
| Bipolar Disorder |
1.7% |
| Cerebral Haemorrhage |
1.7% |
| Coagulopathy |
1.7% |
| Factor Viii Inhibition |
1.7% |
|
| Multi-organ Failure |
11.9% |
| Pyrexia |
11.9% |
| Death |
7.1% |
| Osteonecrosis |
7.1% |
| Thrombosis |
7.1% |
| Cerebral Haemorrhage |
4.8% |
| Drug Ineffective |
4.8% |
| Haematoma |
4.8% |
| Muscle Haemorrhage |
4.8% |
| Renal Haemorrhage |
4.8% |
| Sudden Death |
4.8% |
| Tachycardia |
4.8% |
| Transmission Of An Infectious Agent Via A Medicinal Product |
4.8% |
| Abdominal Pain |
2.4% |
| Agranulocytosis |
2.4% |
| Cerebellar Haemorrhage |
2.4% |
| Cholelithiasis |
2.4% |
| Face Injury |
2.4% |
| Factor Viii Inhibition |
2.4% |
| Hypersensitivity |
2.4% |
|
